{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:10:53Z","timestamp":1778670653905,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["94-03-158-30179"],"award-info":[{"award-number":["94-03-158-30179"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.lfs.2020.118780","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T10:27:57Z","timestamp":1605695277000},"page":"118780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Combination therapy of phosphatidylserine liposome with cyclosporine A improves nephrotoxicity and attenuates delayed-type hypersensitivity response"],"prefix":"10.1016","volume":"265","author":[{"given":"Monika","family":"Komeili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshid","family":"Noorbakhsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamileh","family":"Esmaili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahad","family":"Muhammadnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Partoazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118780_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.urology.2017.05.016","article-title":"Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis-bladder pain syndrome","volume":"107","author":"Crescenze","year":"2017","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00467-018-4145-6","article-title":"Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome","volume":"34","author":"Fujinaga","year":"2019","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118780_bb0015","first-page":"311","article-title":"Worldwide experience with Sandimmune (cyclosporine) in autoimmune diseases: multiple sclerosis, rheumatoid arthritis","volume":"57","author":"Carstens","year":"1990","journal-title":"psoriasis, Mt Sinai J Med"},{"key":"10.1016\/j.lfs.2020.118780_bb0020","first-page":"230386","article-title":"Cyclosporine: a review","volume":"2012","author":"Tedesco","year":"2012","journal-title":"J. Transp. Secur."},{"issue":"12","key":"10.1016\/j.lfs.2020.118780_bb0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1369\/jhc.5A6623.2005","article-title":"Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression","volume":"53","author":"Buffoli","year":"2005","journal-title":"J. Histochem. Cytochem."},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10157-018-1594-y","article-title":"Is medium dose of cyclosporine A effective in treatment of children with steroid-dependent nephrotic syndrome with reduction in corticosteroids dose consumption?","volume":"23","author":"Abedini","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118780_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jphp.12363","article-title":"Thymoquinone improves the kidney and liver changes induced by chronic cyclosporine A treatment and acute renal ischaemia\/reperfusion in rats","volume":"67","author":"Farag","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jss.2014.08.042","article-title":"Effects of antioxidant agents against cyclosporine-induced hepatotoxicity","volume":"193","author":"Akbulut","year":"2015","journal-title":"J. Surg. Res."},{"issue":"7","key":"10.1016\/j.lfs.2020.118780_bb0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/15376516.2017.1333553","article-title":"Rotenone induces nephrotoxicity in rats: oxidative damage and apoptosis","volume":"27","author":"Jiang","year":"2017","journal-title":"Toxicol. Mech. Methods"},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jep.2004.12.017","article-title":"Immunosuppressive properties of an ethyl acetate fraction from Euphorbia royleana","volume":"99","author":"Bani","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2020.118780_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2014.01.055","article-title":"Combination of N-(3\u20324\u2032-dimethoxycinnamoyl) anthranilic acid with cyclosporin A treatment preserves immunosuppressive effect and reduces the side effect of cyclosporin A in rat","volume":"728","author":"Yong-Gang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118780_bb0060","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1681\/ASN.V1061366","article-title":"Newer immunosuppressive drugs: a review","volume":"10","author":"Gummert","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2020.118780_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2012.02.060","article-title":"Docosahexaenoic acid and phosphatidylserine supplementations improve antioxidant activities and cognitive functions of the developing brain on pentylenetetrazol-induced seizure model","volume":"1451","author":"Liu","year":"2012","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.lfs.2020.118780_bb0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11745-001-0820-7","article-title":"A unique antioxidant activity of phosphatidylserine on iron-induced lipid peroxidation of phospholipid bilayers","volume":"36","author":"Dacaranhe","year":"2001","journal-title":"Lipids"},{"issue":"3","key":"10.1016\/j.lfs.2020.118780_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/09205063.2015.1125565","article-title":"Synergy between phenotypic modulation and ROS neutralization in reduction of inflammatory response of hypoxic microglia by using phosphatidylserine and antioxidant containing liposomes","volume":"27","author":"Hosain","year":"2016","journal-title":"Journal of Biomaterials Science. Polymer edition"},{"issue":"7","key":"10.1016\/j.lfs.2020.118780_bb0080","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.freeradbiomed.2006.12.003","article-title":"Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation","volume":"42","author":"Hashioka","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.lfs.2020.118780_bb0085","doi-asserted-by":"crossref","first-page":"11853","DOI":"10.1002\/jcb.28464","article-title":"Hepatoprotective effects of phosphatidylserine liposomes on carbon tetrachloride-induced hepatotoxicity in rats","volume":"120","author":"Yousefi-Manesh","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2020.118780_bb0090","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.4238\/2015.August.10.13","article-title":"Effect of phosphatidylserine on memory in patients and rats with Alzheimer\u2019s disease","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2020.118780_bb0095","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4049\/jimmunol.174.3.1393","article-title":"Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo","volume":"174","author":"Hoffmann","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.118780_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2014.06.002","article-title":"Phosphatidylserine in the brain: metabolism and function","volume":"56","author":"Kim","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnen\/62.2.208","article-title":"Apoptotic PC12 cells exposing phosphatidylserine promote the production of anti-inflammatory and neuroprotective molecules by microglial cells","volume":"62","author":"De Simone","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118780_bb0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1083\/jcb.200110066","article-title":"Tethering and tickling: a new role for the phosphatidylserine receptor","volume":"155","author":"Somersan","year":"2001","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2020.118780_bb0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.cdd.4401836","article-title":"PS externalization: from corpse clearance to drug delivery","volume":"13","author":"Fadeel","year":"2006","journal-title":"Cell Death Differ."},{"issue":"8","key":"10.1016\/j.lfs.2020.118780_bb0120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2217\/cer-2018-0128","article-title":"In vitro antioxidant activity and in vivo wound-healing effect of lecithin liposomes: a comparative study","volume":"8","author":"Nasab","year":"2019","journal-title":"J Comp Eff Res"},{"issue":"1","key":"10.1016\/j.lfs.2020.118780_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0041-1345(02)03900-3","article-title":"Apoptosis and expression of BCL-2 and BAX in cyclosporine-induced experimental renal fibrosis","volume":"35","author":"Rawat","year":"2003","journal-title":"Transplant. Proc."},{"issue":"12","key":"10.1016\/j.lfs.2020.118780_bb0130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.phymed.2016.08.002","article-title":"Phyllanthin from Phyllanthus amarus inhibits cellular and humoral immune responses in Balb\/C mice","volume":"23","author":"Ilangkovan","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.lfs.2020.118780_bb0135","unstructured":"M. Spitz, A. Gearing, M. Callus, L. Spitz, R. Thorpe, Interleukin-2 in vivo: production of and response to interleukin-2 in lymphoid organs undergoing a primary immune response to heterologous erythrocytes, Immunology 54(3) (1985) 527."},{"key":"10.1016\/j.lfs.2020.118780_bb0140","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0041-1345(01)01906-6","article-title":"Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?","author":"Groetzner","year":"2001","journal-title":"Transplant. Proc."},{"issue":"8","key":"10.1016\/j.lfs.2020.118780_bb0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/tri.12553","article-title":"The need for minimization strategies: current problems of immunosuppression","volume":"28","author":"Bamoulid","year":"2015","journal-title":"Transpl. Int."},{"issue":"2 Suppl","key":"10.1016\/j.lfs.2020.118780_bb0150","doi-asserted-by":"crossref","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","article-title":"Cyclosporine nephrotoxicity","volume":"36","author":"Busauschina","year":"2004","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.lfs.2020.118780_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.intimp.2015.07.022","article-title":"Amelioration of cyclosporine induced nephrotoxicity by dipeptidyl peptidase inhibitor vildagliptin","volume":"28","author":"Ateyya","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118780_bb0160","first-page":"613","article-title":"Lipid peroxidation, reactive oxygen species and antioxidative factors in the pathogenesis of gastric mucosal lesions and mechanism of protection against oxidative stress - induced gastric injury","volume":"65","author":"Kwiecien","year":"2014","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118780_bb0165","series-title":"Mouse Models of Innate Immunity","first-page":"101","article-title":"Delayed-type hypersensitivity models in mice","author":"Allen","year":"2013"},{"issue":"12","key":"10.1016\/j.lfs.2020.118780_bb0170","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1084\/jem.20050419","article-title":"IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo","volume":"201","author":"Sawitzki","year":"2005","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4049\/jimmunol.150.2.342","article-title":"Regulation of IFN-gamma and tumor necrosis factor-alpha expression in vivo. Effects of cycloheximide and cyclosporine in normal and lipopolysaccharide-treated mice","volume":"150","author":"Cockfield","year":"1993","journal-title":"J. Immunol."},{"issue":"6380","key":"10.1016\/j.lfs.2020.118780_bb0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/357692a0","article-title":"FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin","volume":"357","author":"O\u2019Keefe","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2020.118780_bb0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nutres.2013.01.006","article-title":"Phosphatidylserine inhibits inflammatory responses in interleukin-1beta-stimulated fibroblast-like synoviocytes and alleviates carrageenan-induced arthritis in rat","volume":"33","author":"Yeom","year":"2013","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2020.118780_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117861","article-title":"Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer\u2019s disease model","volume":"255","author":"Saffari","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118780_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117606","article-title":"Effect of phosphatidylserine on cirrhosis-induced hepatic encephalopathy: response to acute endotoxemia in cirrhotic rats","volume":"253","author":"Zamanian","year":"2020","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.lfs.2020.118780_bb0200","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/cdd.2016.11","article-title":"Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer","volume":"23","author":"Birge","year":"2016","journal-title":"Cell Death & Differentiation"},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/fcp.12244","article-title":"Nanoliposome containing cyclosporine a reduced neuroinflammation responses and improved neurological activities in cerebral ischemia\/reperfusion in rat","volume":"31","author":"Partoazar","year":"2017","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.lfs.2020.118780_bb0210","series-title":"Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof","author":"Rezayat","year":"2015"},{"issue":"6","key":"10.1016\/j.lfs.2020.118780_bb0215","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/sj.bjp.0707302","article-title":"Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo","volume":"151","author":"Ramos","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118780_bb0220","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.nut.2014.10.014","article-title":"Phosphatidylserine and the human brain","volume":"31","author":"Glade","year":"2015","journal-title":"Nutrition"},{"issue":"2","key":"10.1016\/j.lfs.2020.118780_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/phrs.1996.0013","article-title":"A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain?","volume":"33","author":"Pepeu","year":"1996","journal-title":"Pharmacol. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520315332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:45:59Z","timestamp":1758401159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520315332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":45,"alternative-id":["S0024320520315332"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118780","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy of phosphatidylserine liposome with cyclosporine A improves nephrotoxicity and attenuates delayed-type hypersensitivity response","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118780"}}